Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 29.35
-0.05 (-0.17%)
At close: Jul 29, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 2.21 billion as of July 29, 2026.
Market Cap
2.21B
Enterprise Value
1.41B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.35
ChartMarket Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 2.21B, a decrease of -37.75%. That is a compound annual growth rate of -54.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 2.26B | -39.02% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 6.45B |
| Taho Pharmaceuticals | 5.50B |
| TEH SENG Pharmaceutical Mfg. | 2.46B |
| Anbogen Therapeutics | 1.91B |
| Timing Pharmaceutial | 1.69B |
| TSA International | 1.58B |
| Gin Hwa Biotech Incorporation | 1.50B |
| Anya Biopharm | 1.48B |